Why Should You & Your Team Take Part?

The 4th IMPACCT Real World Evidence Summit Europe brings together senior RWE, Evidence Generation, Medical Affairs and Market Access leaders to tackle the challenges shaping the future of real-world evidence. As AI advances and the European Health Data Space (EHDS) creates new opportunities for data access, discover how leading organisations are navigating fragmented data landscapes, building regulatory-grade evidence and demonstrating the strategic value of RWE.

Through real-world case studies spanning the evidence lifecycle, explore AI-driven evidence generation, federated data networks, patient-generated data, JCA readiness and integrated evidence planning. Beyond the presentations, dedicated networking sessions, interactive roundtables and problem-solving clinics offer the opportunity to exchange practical insights, challenge established approaches and build meaningful connections with peers facing the same challenges.

Crowd clapping

Unmissable Event Highlights

Put AI Into Practice Across the RWE Lifecycle

Move beyond the AI hype to discover what is delivering real value in RWE today. Explore how leading teams are applying AI to study design, treatment pattern analysis, data abstraction and evidence generation, while navigating validation, governance and the limitations of emerging technologies.

Hear from:

Mirko Ristanovic

Thomas Lanz

Emmi Tikkanen

Unlock Europe's Fragmented Data Through Innovative RWE Approaches

Discover how leading organisations are connecting fragmented datasets to generate richer, more actionable evidence. Explore federated data networks, cross-source collaboration and emerging data sources, including patient-generated data and wearables, to overcome data access challenges and strengthen evidence generation across complex European healthcare systems.

Hear from:

Carsten Moeller

Melpomeni Styliadou

Build RWE That Stands Up to Regulatory & HTA Scrutiny

Explore how to strengthen the credibility and acceptance of real-world evidence across Europe. From improving data quality and addressing measurement error to preparing for Joint Clinical Assessment (JCA), discover what it takes to generate robust, regulatory-grade evidence that meets evolving regulatory and HTA expectations.

Hear from:

Stefania Pirondi

Jesica Levingston Mac Leod

Embed RWE Earlier to Shape Drug Development & Evidence Strategy

Move beyond generating evidence at the point of submission. Discover how leading organisations are embedding RWE earlier to inform target populations, clinical development, integrated evidence planning and market access strategies, helping teams identify evidence gaps sooner and demonstrate value throughout the product lifecycle.

Hear from:

Aliki Taylor

Emmanuelle Boutmy

Build Your Strategic RWE Network Through Meaningful Peer Connections

Go beyond exchanging business cards and connect with senior RWE, Evidence Generation, Medical Affairs and Market Access leaders from across the industry. Through dedicated networking, interactive roundtables, problem-solving clinics and candid peer discussions, share challenges, pressure-test ideas and build relationships that continue beyond the summit.

Connect with peers from:

Abbvie - 4th IMPACCT Real World Evidence Summit Europe
Astrazeneca - 4th IMPACCT Real World Evidence Summit Europe
Boehringer Ingelheim - 4th IMPACCT Real World Evidence Summit Europe
Chiesi - 4th IMPACCT Real World Evidence Summit Europe
Merck - 4th IMPACCT Real World Evidence Summit Europe
Otsuka - 4th IMPACCT Real World Evidence Summit Europe
Sanofi - 4th IMPACCT Real World Evidence Summit Europe
UCB - 4th IMPACCT Real World Evidence Summit Europe

and more.

Explore the Full Event Guide

  • Explore real-world case studies from Pfizer, AstraZeneca, Bayer, UCB and more
  • Discover practical AI applications across the RWE lifecycle
  • Unpack Europe's evolving health data landscape and EHDS
  • Explore new interactive sessions, including RWE Confessions and our Problem-Solving Clinic
  • Find dedicated networking opportunities to connect with senior RWE, Evidence Generation and Market Access leaders
4th IMPACCT Real World Evidence Summit Europe

Attending Companies Include:

Abbvie - 4th IMPACCT Real World Evidence Summit Europe
Alfasigma - 4th IMPACCT Real World Evidence Summit Europe
Astrazeneca - 4th IMPACCT Real World Evidence Summit Europe
Bayer - 4th IMPACCT Real World Evidence Summit Europe
Boehringer Ingelheim - 4th IMPACCT Real World Evidence Summit Europe
Chiesi - 4th IMPACCT Real World Evidence Summit Europe
Gilead - 4th IMPACCT Real World Evidence Summit Europe
LEO Pharma - 4th IMPACCT Real World Evidence Summit Europe
Merck - 4th IMPACCT Real World Evidence Summit Europe
Novartis - 4th IMPACCT Real World Evidence Summit Europe
novo nordisk - 4th IMPACCT Real World Evidence Summit Europe
Otsuka - 4th IMPACCT Real World Evidence Summit Europe
Pfizer - 4th IMPACCT Real World Evidence Summit Europe
Takeda - 4th IMPACCT Real World Evidence Summit Europe
UCB - 4th IMPACCT Real World Evidence Summit Europe
Speaker addressing crowd
Explore the 2027 Agenda

Discover practical insights from leading RWE, Evidence Generation and Market Access experts through real-world case studies, interactive discussions and hands-on workshops.

Crowd Networking
Partner With Us

Showcase how your solutions help pharma and biotech teams unlock real-world data and advance evidence generation, from data providers and AI analytics platforms to RWE consultancy.

Panel Discussion
Connect Across the RWE Lifecycle

Network with senior leaders across RWE, Medical Affairs and Market Access to exchange practical insights, tackle shared challenges and build collaborations that maximise the value of real-world evidence.